Stock Market

The video game industry is still buzzing from last week’s announcement that Microsoft (NASDAQ:MSFT) is buying Activision Blizzard (NASDAQ:ATVI). And for investors, the deal means its time to parse out the stock winners and losers in the deal. Microsoft’s $68.7 billion deal to buy Activision will make it the globe’s third-largest gaming company and the

From the outset, neo-banking leader SoFi Technologies (NASDAQ:SOFI) sought to help people from all walks of life to manage their money. It’s an ambitious vision that some loyal SOFI stock holders undoubtedly share. Source: rafapress / Shutterstock.com The idea of taking on the big banks and handing the power back to the people is exciting.

Earlier in January, Virgin Galactic (NYSE:SPCE) stock fell through its October 2019 debut price of $11.75. Little did shareholders know that the stock would fall another $3.75 over the next three weeks. Source: rafapress / Shutterstock.com As I write this, it is below $9 and nowhere near its all-time high of $62.80 reached in June

Shares of up-and-coming electric vehicle EV startup Canoo (NASDAQ:GOEV) have shed more than 40% of their value in the past six months. GOEV stock has fallen more than 70% from its 52-week high price of $18.88. Overall, its first year of trading was forgettable. Source: shutterstock.com/rafapress 2022 could be a landmark year for the company,

It’s no secret that Twitter (NASDAQ:TWTR) underwent a major transition, as Jack Dorsey stepped down as its  CEO and was replaced by Parag Agrawal in November of last year. The change put the loyal owners of TWTR stock at a crossroads: should they keep the shares or dump them? Source: Worawee Meepian / Shutterstock.com It’s a

Market conditions continue to work against Palantir Technologies (NYSE:PLTR). But, as it sinks down below $15 per share, PLTR stock may now be entering the buy zone. At least, it may appear that way to investors who see the data analytics software provider as a long-term play. Source: Ascannio / Shutterstock.com For investors looking at PLTR

The stock market is having a bit of a tizzy in anticipation of a Federal Reserve meeting this week. The Fed will announce its plans on how fast it wants to control inflation this year. Meanwhile, investors are pricing in what is likely too much bearishness just in case. In other words, they are selling

Do you like to ride on the backs of cryptocurrency whales? If so, then you’ll definitely want to check out Fantom (CCC:FTM-USD). Apparently, large-scale traders may be showing interest in Fantom in early 2022. Source: Wit Olszewski / Shutterstock.com Reportedly, one crypto whale recently purchased 500,000 FTM. That order was valued at $1,110,000 – clearly, somebody’s

With the growth of online retail, I can understand the attraction retail investors have to ContextLogic (NASDAQ:WISH). However, WISH stock is down about 90% from its 52-week high. And the chart hasn’t given bulls much to be encouraged about since early summer.  Source: sdx15 / Shutterstock.com That was when I first wrote about WISH stock.

Bakkt Holdings (NYSE:BKKT) stock has had a mystifying run over the past six months or so. The company launched via a special purpose acquisition company (SPAC) and almost immediately skyrocketed from $10 to $40. Source: iQoncept/ShutterStock.com These gains would not last, however. BKKT stock hit $40 in October. By December, it was back down to

We finally have more clarity regarding when DiDi Global (NYSE:DIDI) will list in Hong Kong. According to a South China Morning Post report, shares could list as early as the second quarter of this year. The company is set to delist in the U.S. and offer a one-for-one exchange for their shares. It caps a

If Twitter (NYSE:TWTR) is going to improve in 2022, it will have to find new ways to attract users. But how it will manage to do that is still up in the air. And that’s why TWTR stock is bleeding these days. Twitter currently trades at $35.10, down more than 18% since the beginning of

Shares of work management platform Asana (NYSE:ASAN) have started 2022 in a slump after roughly doubling in 2021. Since they have a 52-week range of $25.41-$145.79, investors may be wondering why the latest close of $53.08 has ASAN stock about 64% off its highs. Several plausible factors are supporting this sharp selloff. So is ASAN stock

Investors in Novavax (NASDAQ:NVAX) can’t catch a break — whether the news is positive or negative. One month ago, NVAX stock was trading for above $200 per share. Since then, it’s plummeted 55% to around $90 a share. Despite my longstanding bullishness on the Covid-19 vaccine play, I’ll admit it’s debatable whether NVAX stock is

Shares of Matterport (NASDAQ:MTTR) have started 2022 with a very negative performance. MTTR stock has already lost over 40% year to date, closing at $12.89 on Jan. 19. Such a big loss in such a short time — less than a month — signals negative momentum for the technology company. Source: Matterport Back in December 2021,

Canadian cannabis grower, retailer and investment firm Sundial Growers (NASDAQ:SNDL) had its 15 minutes of meme stock fame a little less than a year ago. Shares rocketed 725% higher between the start of 2021 and its high of nearly $4 in February. But since then, SNDL stock has plummeted to around 52 cents a share

In several prior articles on InvestorPlace, I mentioned that you should not read into any one single news item or development. You shouldn’t ignore it but you must also consider the bigger picture. But with Coupang (NYSE:CPNG), stock this understanding may require a few tweaks. Source: Ki young / Shutterstock.com Coupang is performing so poorly

If you’ve been waiting to buy Lucid Group (NASDAQ:LCID) on the cheap, this may be your chance. LCID stock currently sits 32% below its high of $57.75, made in mid-November. Shares have fallen nearly 14% in the past week alone as the company approaches the lockup expiration for legacy shareholders. Source: ggTravelDiary / Shutterstock.com Following

I remain of two minds regarding Clover Health Investments (NASDAQ:CLOV). On the one hand, I like the vision of chief technology officer Andrew Toy. Most of America’s healthcare bills are built on chronic conditions like heart disease and diabetes. Data and virtual doctor visits can improve compliance and lower costs. Source: Wirestock Creators / Shutterstock.com On

Among early stage electric vehicle (EV) stocks, Rivian Automotive (NASDAQ:RIVN) is one that’s been placed in the winner’s circle even though it has yet to cross the finish line. And while RIVN stock may be down big from its all-time high, hit right after its IPO, shares sport a “priced for perfection” valuation. Source: Michael Vi /